6 结果
BACKGROUND
Clostridium difficile infection (CDI) is a significant cause of antibiotic-associated nosocomial diarrhea. While discontinuation of the offending antibiotic is the ideal strategy to control the disease, in most cases, treatment with antimicrobial agents active against C. difficile is
FIELD OF THE INVENTION
This invention relates to the use of Lactobacillus reuteri for the inhibition of disease states associated with Cryptosporidium parvum.
BACKGROUND OF INVENTION
Cryptosporidiosis is caused by the protozoan parasite Cryptosporidium parvum (C. parvum). Historically, C. parvum had
FIELD OF THE INVENTION
This invention relates to the use of Lactobacillus acidophilus for the inhibition of disease states associated with Cryptosporidium parvum.
BACKGROUND OF INVENTION
Cryptosporidiosis is caused by the protozoan parasite Cryptosporidium parvum (C. parvum). Historically, C. parvum
FIELD OF THE INVENTION
The present invention relates to a traditional Chinese medicine (TCM) preparation for treating Acquired Immune Deficiency Syndrome (AIDS) and its preparation method. The preparation is a multitarget drug, which not only can improve the immunological function, but also has
The present invention relates to substituted 4(5)-(1-indanyl and 1-indanylmethyl and 1-indanylmethylen)imidazoles and 4(5)-[1-(1,2,3,4-tetrahydronaphthyl and 1,2,3,4-tetrahydronaphthylmethyl and 1,2,3,4-tetrahydronaphthylmethylen]imidazoles and to their isomers, pharmaceutically acceptable salts and
The present invention relates to substituted 4(5)-(1-indanyl and 1-indanylmethyl and 1-indanylmethylen)imidazoles and 4(5)-[1-(1,2,3,4-tetrahydronaphthyl and 1,2,3,4-tetrahydronaphthylmethyl and 1,2,3,4-tetrahydronaphthylmethylen]imidazoles and to their isomers, pharmaceutically acceptable salts and